Showcases Stock ranks Forex

Kitov Pharma Ltd (KTOV)
  0 (0%)
Open: Pre. Close:
High: Low:
Volume: Market Cap: 0M
Prices Prediction (Update @5:00pm)
If tomorrow: Open lower Open higher
High: 4.707 - 4.731 4.731 - 4.75
Low: 4.486 - 4.511 4.511 - 4.531
Close: 4.573 - 4.613 4.613 - 4.645
Stock Technical Analysis
Target: Six months: 5.95
One year: 6.94
Support: Support1: 4.24
Support2: 3.71
Resistance: Resistance1: 5.09
Resistance2: 5.95
Pivot: 4.24
Moving Averages: MA(5): 4.62
MA(20): 4.17
MA(100): 4.22
MA(250): 5.11
MACD: MACD(12,26): 0.14
Signal(12,26,9): 0.06
%K %D: %K(14,3): 63.92
%D(3): 70.64
RSI: RSI(14): 61.27
52-Week: High:
Change(%): -33.3
Average Vol(K): 3-Month: 40391
10-Days: 75709
Price, MAs and Bollinger Bands
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.

KTOV has closed below upper band by 20.4%. Bollinger Bands are 87.6% wider than normal. The large width of the bands suggest high volatility as compared to KTOV's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.
Stock chart
Stock News
Thu, 10 Dec 2020
Kitov Announces Name Change to Purple Biotech Ltd. - GlobeNewswire

Mon, 16 Nov 2020
What Can We Learn About Kitov Pharma's (TLV:KTOV) CEO Compensation? - Simply Wall St

Tue, 27 Oct 2020
Kitov Pharma Receives Notice of Allowance for a U.S. Patent Covering its Anti-Cancer Drug Candidate, NT219 - GlobeNewswire

Wed, 12 Aug 2020
Kitov Pharma Announces ADS Ratio Change Nasdaq:PPBT - GlobeNewswire

Tue, 11 Aug 2020
Kitov Pharma Provides Corporate Update and Reports First Half 2020 Financial Results - GlobeNewswire

Wed, 08 Jul 2020
Kitov Pharma Receives Notice of Intention to Grant a European Patent Covering CM24, its anti-CEACAM1 Antibody - GlobeNewswire

Financial Analysis
Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company's ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Stock Basics & Statistics
Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 17.21
Shares Float (M) 15.45
% Held by Insiders 1.91
% Held by Institutions 14.58
Shares Short (K) 44
Shares Short Prior Month (K) 184
Stock Financials
EPS -7.800
Book Value (p.s.) 3.540
Profit Margin
Operating Margin -753.90
Return on Assets (ttm) -9.1
Return on Equity (ttm) -92.0
Qtrly Rev. Growth
Gross Profit (p.s.) 0.058
Sales Per Share 0.058
EBITDA (p.s.) -0.438
Qtrly Earnings Growth
Operating Cash Flow (M) -7.95
Levered Free Cash Flow (M) 21.78
Stock Valuation
PE Ratio -0.59
PEG Ratio
Price to Book value 1.30
Price to Sales 79.34
Price to Cash Flow -9.98
Stock Dividends
Dividend Yield
Dividend Growth

Stoxline Lite

Stoxline Pro

Stock Chart

Option Calculator